Daniel del Castillo Déjardin

ORCID: 0000-0003-0456-3102
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bariatric Surgery and Outcomes
  • Body Contouring and Surgery
  • Diet and metabolism studies
  • Maritime Navigation and Safety
  • Surgical Simulation and Training
  • Esophageal and GI Pathology
  • Gastrointestinal disorders and treatments
  • Pancreatic and Hepatic Oncology Research
  • Anatomy and Medical Technology
  • Regulation of Appetite and Obesity
  • Obesity and Health Practices
  • Liver Disease Diagnosis and Treatment
  • Diabetes and associated disorders
  • Pancreatitis Pathology and Treatment
  • Retinal Diseases and Treatments
  • Adipokines, Inflammation, and Metabolic Diseases
  • Gastrointestinal Tumor Research and Treatment
  • Cardiac, Anesthesia and Surgical Outcomes
  • Peroxisome Proliferator-Activated Receptors
  • Maritime Security and History
  • Retinal Imaging and Analysis
  • Gastric Cancer Management and Outcomes
  • Pharmacology and Obesity Treatment
  • Adrenal and Paraganglionic Tumors
  • Simulation-Based Education in Healthcare

Virtual High School
2024

Hospital Oncológico Docente "Conrado Benítez García"
2024

Institut d'Investigació Sanitària Pere Virgili
2011-2021

Hospital Universitari Sant Joan de Reus
2011-2020

Universitat Rovira i Virgili
2010-2020

Instituto de Salud Pública de Chile
1981-2010

Marche Polytechnic University
2004

Objective The adipocyte/macrophage fatty acid-binding protein 4 (FABP4) has been described as a biomarker for adiposity and metabolic syndrome (MS). aims of this study were to assess the relationship between FABP4 inflammatory cytokines related obesity, evaluate mRNA expression in visceral subcutaneous adipose tissue non-diabetic morbidly obese women versus healthy lean women. Methods We analyzed circulating levels 81 Spanish women: 38 (body mass index (BMI)<25 kg/m 2 ) 43 (BMI>40 )....

10.1530/eje-10-1195 article EN European Journal of Endocrinology 2011-01-22

Abstract Objective: We aimed to analyze the retinol binding protein‐4 (RBP4) messenger RNA (mRNA) expression profiles in adipose tissues and liver of morbidly obese (MO) women with or without nonalcoholic fatty disease (NAFLD), study relationships other pro‐ anti‐inflammatory adipokines vivo vitro. Design Methods: performed a cross‐sectional analysis subcutaneous tissue (SAT), visceral (VAT) samples from four lean 45 MO NAFLD by enzyme‐linked immunosorbent assay real‐time reverse...

10.1002/oby.20233 article EN Obesity 2013-01-01

Objective The aim of this study was to analyse the expression crucial genes in fatty acid metabolism visceral (VAT) and subcutaneous (SAT) adipose tissue samples from morbidly obese women. Methods VAT SAT key 145 women (MO, BMI > 40 Kg/m 2 ) 18 normal weight control by RT‐PCR Western Blot analyzed. Results In SAT, levels related lipogenesis oxidation were significantly lower MO than controls. VAT, most lipogenic studied had similar cohort. Regarding inflammation, IL6 higher both tissues...

10.1002/oby.20809 article EN Obesity 2014-06-13

Recent studies report the effect of bariatric surgery on glycaemia control and prevention type-2-diabetes in obese patients. This study is about pathophysiological mechanisms associated to these changes.Circulating levels receptors tumor necrosis factor (TNF-RI, TNF-RII), visfatin, high molecular weight (HMW) adiponectin, C reactive protein (CRP) 30 morbidly women (body mass index, BMI>40 kg/m(2) ) 60 normal-weight controls (BMI>25 were analyzed. Morbidly studied at three time-points: before...

10.1002/oby.20470 article EN Obesity 2013-03-30

Summary Sjögren's syndrome (SS) is an autoimmune disease characterized by clonal B cell attack of the exocrine glands and dysregulated expression cell-activating factor (BAFF). Based upon current data increased rates lymphoid malignancy, as non-Hodgkin's lymphoma (NHL) associated with SS, we propose detection rearrangements immunoglobulin heavy chain (IgH) gene in those patients a predictor malignant expansion. To test our proposal, examined IgH SS (60) healthy control subjects (42) having...

10.1111/j.1365-2249.2010.04144.x article EN Clinical & Experimental Immunology 2010-04-09
Coming Soon ...